Apfed

Apfed is dedicated to improving the lives of people living with eosinophil-associated diseases through education, awareness, research, advocacy, and support initiatives that advance earlier diagnosis, improved care, and better outcomes for patients and families.

Research: Apfed awarded two researchers each a $100,000 2-year hope pilot grant to support projects focused on non-invasive biomarkers for eoe and molecular drivers of heterogeneity in egpa and asthma, sponsored abstract awards to support early-career investigators, and provided support to the international eosinophil society professional symposium for researchers and clinicians.

Apfed is a 501(c)(3) nonprofit (EIN 76-0700153) based in Atlanta, GA.